Lars Korsholm
Overview
Explore the profile of Lars Korsholm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caram-Deelder C, McKinnon Edwards H, Zdanowicz J, van den Akker T, Birkegard C, Blatny J, et al.
J Clin Med
. 2024 May;
13(9).
PMID: 38731185
: Despite a range of available treatments, it is still sometimes challenging to treat patients with severe post-partum hemorrhage (sPPH). Objective: This study evaluated the efficacy and safety of recombinant...
2.
Klamroth R, Hampton K, Trakymiene S, Korsholm L, Carcao M
Patient Prefer Adherence
. 2021 Nov;
15:2443-2454.
PMID: 34764641
Purpose: To illustrate the benefits of the extended half-life (EHL) recombinant factor VIII product N8-GP (Esperoct, turoctocog alfa pegol) by describing individual cases of patients with severe hemophilia A treated...
3.
Yaish H, Matsushita T, Belhani M, Jimenez-Yuste V, Kavakli K, Korsholm L, et al.
Haemophilia
. 2019 Dec;
26(1):64-72.
PMID: 31816159
Introduction: Turoctocog alfa is a recombinant, B domain-truncated factor VIII (FVIII) approved for patients with haemophilia A. Aim: To evaluate the safety and efficacy of turoctocog alfa in previously untreated...
4.
Lentz S, Janic D, Kavakli K, Miljic P, Oldenburg J, Ozelo M, et al.
Haemophilia
. 2018 Nov;
24(6):e391-e394.
PMID: 30402994
Introduction: Turoctocog alfa is a recombinant factor VIII (FVIII) molecule, approved for treatment and prophylaxis of bleeding in patients with haemophilia A. In the guardian 1 (adolescents/adults) and guardian 3...
5.
Franz C, Moller N, Korsholm L, Jespersen E, Hebert J, Wedderkopp N
Sci Rep
. 2017 Sep;
7(1):11598.
PMID: 28912463
Spinal pain and physical inactivity are critical public health issues. We investigated the prospective associations of physical activity intensity with spinal pain in children. Physical activity was quantified with accelerometry...
6.
Kjaer P, Korsholm L, Leboeuf-Yde C, Hestbaek L, Bendix T
BMC Musculoskelet Disord
. 2017 Jan;
18(1):28.
PMID: 28109244
Background: Few longitudinal studies have described the variation in LBP and its impact over time at an individual level. The aims of this study were to: 1) determine the prevalence...
7.
Rodbard H, Gough S, Lane W, Korsholm L, Bretler D, Handelsman Y
Endocr Pract
. 2013 Nov;
20(4):285-92.
PMID: 24246344
Objective: This meta-analysis of 5 trials from the Phase 3a insulin degludec (IDeg) clinical trial program evaluated the risk of hypoglycemia in a subset of subjects with type 2 diabetes...
8.
Olesen L, Kristensen P, Korsholm L, Froberg K
Pediatrics
. 2013 Oct;
132(5):e1310-8.
PMID: 24127470
Objective: To identify correlates of objectively measured moderate and vigorous physical activity (MVPA) in children during preschool attendance. Methods: This cross-sectional study included data from 426 apparently healthy Danish children...
9.
Hancock M, Kjaer P, Korsholm L, Kent P
Phys Ther
. 2013 Feb;
93(6):852-9.
PMID: 23431217
With the rapidly expanding number of studies reporting on treatment subgroups come new challenges in analyzing and interpreting this sometimes complex area of the literature. This article discusses 3 important...
10.
ONeill L, Hartvigsen J, Wallstedt B, Korsholm L, Eika B
Med Educ
. 2011 Oct;
45(11):1111-20.
PMID: 21988626
Context: Very few studies have reported on the effect of admission tests on medical school dropout. The main aim of this study was to evaluate the predictive validity of non-grade-based...